Furthermore, clinical research has found that FBN2 gene methylation exhibited in 63% of tumor samples of patients with primary colorectal carcinoma, and FBN2 might be an early and frequent event in precancerous and cancerous lesions of the colon and rectum [68]. The gene discussed is FBN2; the disease is colorectal carcinoma.